These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24552080)

  • 21. Natural rubber-containing medical devices; user labelling--FDA. Final rule; interpretation.
    Fed Regist; 1998 May; 63(87):24934-5. PubMed ID: 10179326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nutrition labelling: perspectives of a bi-national agency for Australia and New Zealand.
    Curran MA
    Asia Pac J Clin Nutr; 2002; 11(2):S72-6. PubMed ID: 12074190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical device labeling and advertising: an overview.
    Basile EM; Armentrout E; Reeves KN
    Food Drug Law J; 1999; 54(4):519-33. PubMed ID: 11824451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in FDA enforcement activities following changes in federal administration: the case of regulatory letters released to pharmaceutical companies.
    Nguyen D; Seoane-Vazquez E; Rodriguez-Monguio R; Montagne M
    BMC Health Serv Res; 2013 Jan; 13():27. PubMed ID: 23339419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amended economic impact analysis of final rule requiring use of labeling on natural rubber containing devices--FDA. Final rule; amended economic analysis statement.
    Fed Regist; 1998 Jun; 63(104):29552-90. PubMed ID: 10179863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Food allergen labeling in the USA and Europe.
    Taylor SL; Hefle SL
    Curr Opin Allergy Clin Immunol; 2006 Jun; 6(3):186-90. PubMed ID: 16670512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Food and Drug Administration's proposed labeling rules for protein.
    Henley EC
    J Am Diet Assoc; 1992 Mar; 92(3):293-4, 296. PubMed ID: 1552126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The US Food and Drug Administration and probiotics: regulatory categorization.
    Degnan FH
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S133-6; discussion S144-51. PubMed ID: 18181719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exemption from federal preemption of state and local cigarette and smokeless tobacco requirements; revocation. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(216):66636. PubMed ID: 11503697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dietary supplements: how they are used and regulated.
    Hathcock J
    J Nutr; 2001 Mar; 131(3s):1114S-7S. PubMed ID: 11238828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Origins of the prohibition against off-label promotion.
    Coleman TS
    Food Drug Law J; 2014; 69(2):161-236, i. PubMed ID: 25163210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Your business in court and at federal agencies: 2010 - 2011.
    Reiss JB; Crowder D; Simons B; Pleskov I; Davis T; Nugent P
    Food Drug Law J; 2012; 67(2):243-92, iii. PubMed ID: 24620420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Balancing consumer protection and scientific integrity in the face of uncertainty: the example of gluten-free foods.
    McCabe MS
    Food Drug Law J; 2010; 65(2):367-90, iii. PubMed ID: 24475546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Food labeling; nutrient content claims, definition of sodium levels for the term "healthy." Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Sep; 70(188):56828-49. PubMed ID: 16193594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDA has the legal authority to adopt a threshold of toxicological concern (TTC) for substances in food at trace levels.
    Hahn MJ
    Food Drug Law J; 2010; 65(2):217-30, i. PubMed ID: 24475540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does Sackett foreshadow the end of non-reviewability for FDA warning letters?
    DeRuyter K
    Food Drug Law J; 2013; 68(3):241-58, i. PubMed ID: 24640609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The importance of GRAS to the functional food and nutraceutical industries.
    Burdock GA; Carabin IG; Griffiths JC
    Toxicology; 2006 Apr; 221(1):17-27. PubMed ID: 16483705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Federal preemption of common law tort awards by the Federal Food, Drug, and Cosmetic Act.
    Carrier MK
    Food Drug Law J; 1996; 51(4):509-611. PubMed ID: 11797729
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.
    Pinkerton JV; Pickar JH
    Menopause; 2016 Feb; 23(2):215-23. PubMed ID: 26418479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.